Roivant Sciences Ltd. — Director's Dealing 2025

Mar 25, 2025

SEC Form 4 — Statement of Changes in Beneficial Ownership

Issuer: Roivant Sciences Ltd. (ROIV)
CIK: 0001635088
Period of Report: 2025-03-20

Reporting Person: Humes Jennifer (N/A)

Non-Derivative Transactions

Date	Security	Code	Shares	Price	A/D	Holdings After	Ownership
2025-03-20	Common Shares	A	112255	—	Acquired	112255	Direct

Derivative Transactions

Date	Security	Exercise Price	Code	Shares	A/D	Expiration	Underlying	Ownership
2025-03-20	Stock Option (Right to Buy)	$10.97	A	115108	Acquired	2035-03-19	Common Shares (115108)	Direct

Footnotes

F1: Award of restricted stock units with respect to Common Shares ("RSUs") with a vesting commencement date of March 20, 2025. These RSUs vest (i) 25% on the first anniversary of the vesting commencement date and (ii) in twelve (12) successive equal quarterly installments thereafter, subject to the reporting person's Continuous Service through each applicable vesting date.

F2: Award of stock options to purchase Common Shares with a vesting commencement date of February 20, 2025. These options vest and become exercisable (i) 25% on the first anniversary of the vesting commencement date and (ii) in thirty-six (36) successive equal monthly installments thereafter, subject to the reporting person's Continuous Service through each applicable vesting date.